Astal Laboratories Board of Directors
Get the latest insights into the leadership at Astal Laboratories. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mahendra Kumar | Company Secretary & Compliance Officer |
| Sudheer Karna Kankanala | Whole Time Director |
| Maggidi Venkatesh | Non Executive Director |
| Birendrakumar Sahoo | Non Executive Independent Director |
| Radhakishore Pandrangi | Non Executive Independent Director |
| Hemachakrapani Bangaraiahgari | Non Executive Independent Director |
| Julius Paul Reinhard Paschke | Non Executive Independent Director |
| Shailaja Ravikanti | Non Executive Director |
Astal Laboratories FAQs
The board at Astal Laboratories consists of experienced professionals, including Mahendra Kumar, Sudheer Karna Kankanala, and others, overseeing the company’s strategic and corporate governance.
Directors at Astal Laboratories are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mahendra Kumar is the current chairman at Astal Laboratories.
Executive directors at Astal Laboratories are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Astal Laboratories adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Astal Laboratories, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.
